Literature DB >> 18025337

Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?

Mary T Austin1, Benjamin K Poulose, Wayne A Ray, Patrick G Arbogast, Irene D Feurer, C Wright Pinson.   

Abstract

OBJECTIVE: To examine the impact of the Model for End-stage Liver Disease (MELD) on waiting list mortality.
DESIGN: Interrupted time series with a nominal inception point of the intervention on February 27, 2002.
SETTING: United Network for Organ Sharing Standard Transplant Analysis and Research file data from March 1, 1999, to July 30, 2004. PARTICIPANTS: All adult candidates on the waiting list for liver transplantation in the United States during the study period. INTERVENTION: Implementation of the MELD policy. MAIN OUTCOME MEASURES: Waiting list mortality, waiting time to transplantation, number of new registrants, and posttransplantation survival.
RESULTS: Although no preintervention trend was identified, the policy change was associated with an immediate effect of increasing waiting list mortality by 2.2 deaths per 1000 registrants per month (from approximately 11 to 13 deaths per 1000 registrants per month; 95% confidence interval [CI], 1.1 to 3.4; P = .001) followed by a postintervention decline in waiting list mortality over time (-0.09 death per 1000 registrants per month; 95% CI, -0.16 to -0.03; P <.001). An immediate effect of decreased waiting time was also noted (from approximately 294 to 250 days; -44.4 days; 95% CI, -77.1 to -11.7 days; P <.001), which reached a new, lower postintervention steady state. The intervention had no effect on the number of new registrants listed per month or on 3- and 6-month posttransplantation survival.
CONCLUSION: After an initial increase in waiting list mortality, the implementation of the MELD-based allocation policy was associated with an overall decline in waiting list mortality and time to transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 18025337     DOI: 10.1001/archsurg.142.11.1079

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  14 in total

1.  Model for end-stage liver disease exceptions committee activity in Argentina: does it provide justice and equity among adult patients waiting for a liver transplant?

Authors:  Lucas McCormack; Adrián Gadano; Javrer Lendoire; Emilio Quiñonez; Oscar Imventarza; Oscar Andriani; Lorenzo Toselli; Octavio Gil; Gabriel Gondolesi; Liliana Bisigniano; Eduardo De Santibañes
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

2.  Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era.

Authors:  David Goldberg; Benjamin French; Arwin Thomasson; K Rajender Reddy; Scott D Halpern
Journal:  Liver Transpl       Date:  2011-11       Impact factor: 5.799

3.  Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.

Authors:  David Goldberg; Benjamin French; Peter Abt; Sandy Feng; Andrew M Cameron
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

4.  Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.

Authors:  Allyson Hart; David P Schladt; Jessica Zeglin; Joshua Pyke; W Ray Kim; John R Lake; John P Roberts; Ryutaro Hirose; David C Mulligan; Bertram L Kasiske; Jon J Snyder; Ajay K Israni
Journal:  Transplantation       Date:  2016-10       Impact factor: 4.939

Review 5.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

6.  Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States?

Authors:  L McCormack; A Gadano; J Lendoire; O Imventarza; O Andriani; O Gil; L Toselli; L Bisigniano; E de Santibañes
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

7.  Waiting list mortality among children listed for heart transplantation in the United States.

Authors:  Christopher S D Almond; Ravi R Thiagarajan; Gary E Piercey; Kimberlee Gauvreau; Elizabeth D Blume; Heather J Bastardi; Francis Fynn-Thompson; T P Singh
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

Review 8.  [Liver transplantation: indications and results].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

9.  Impact of estimated liver volume and liver weight on gender disparity in liver transplantation.

Authors:  Ayse L Mindikoglu; Sukru H Emre; Laurence S Magder
Journal:  Liver Transpl       Date:  2012-12-12       Impact factor: 5.799

Review 10.  [Model for end-stage liver disease. New basis of allocation for liver transplantations].

Authors:  G E Jung; J Encke; J Schmidt; A Rahmel
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.